Dr. David Bailie: resurfacing arthroplasty of the shoulder (specialized partial replacement)

Dr. Bailie has been doing resurfacing arthroplasty of the shoulder (specialized partial replacement) since the FDA approved their use in 2001. In fact, he was instrumental in bringing the technology to the US Orthopedic market with Biomet. This procedure is best for younger, active patients who are in need of pain relief from arthritis of the shoulder but too young to consider a full replacement.

He has performed this surgery on hundreds of patients with excellent mid-term and long term results. This includes active Olympic athletes, a Hall of Fame Major League Baseball player, many physicians/triathletes and "weekend warriors" who desire to maintain a very active lifestyle.

Below is a link to the video:

http://ortho.broadcastmed.com/4532/videos/bone-conserving-humeral-resurfacing

The video is a live surgery he performed as a webcast- broadcast live worldwide with an onsite moderator who assisted Dr Bailie in question/answers during the surgery. Viewers could send in questions live while watching the surgery and Dr. Bailie would demonstrate aspects of the procedure to help educate the viewers.

In addition, his work was published in the Journal of Bone and Joint Surgery, the most prestigious journal in Orthopedics Worldwide. He was asked to also write a book chapter in the prestigious text, THE SHOULDER (Ed Craig, editor) on this topic, which is shown below, and describes the procedure and his results. Long term data have shown that this procedure performs well over 10 years.

For more information, you may visit his website at www.SportsMedDoc.com where you can reach him via email.

Additionally, the following link is the chapter in the text: http://sportsmeddoc.com/files/DSB_complete_Chapter.pdf

TOCA
602-277-6211
www.tocamd.com

TOCA is pleased to announce that David S Bailie MD has been selected as a principal investigator of a new stemless total shoulder replacement device.

TOCA is pleased to announce that David S Bailie MD has been selected as a principal investigator of a new stemless total shoulder replacement device. This is a randomized study being conducted at 12 FDA approved medical facilities in the US. Dr. Bailie is the only orthopedic surgeon approved to use this device in the western US (west of  Memphis, TN). 

This FDA approved study is being sponsored by Biomet Orthopedics ( a worldwide manufacturer/distributor of Orthopedic devices, www.Biomet.com). 

Dr. Bailie has been selected by the FDA and the Western Institutional Review Board to participate and enroll qualified patients. The device has already been released and is currently being used in several European countries and the UK. Because the device is uniquely different than any current shoulder replacement on the market, in the US it requires a specifically designed FDA approved study, to be conducted by select surgeons, prior to general release to the remainder of the medical community. Until the study is complete (approximately 5-7 years), it will only be available as part of this study. Dr. Bailie is very excited to have been asked to participate in this "cutting-edge" research and be able to offer his patients a unique opportunity to participate. Participating orthopedic surgeons is by invitation only.

As criteria for patients to be included in this study is very specific and narrow, only those potential patients who are seen and examined personally by Dr. Bailie can be considered. This study will be performed under strict FDA and IRB monitoring until it is completed.



TOCA
602-277-6211
www.tocamd.com